21 research outputs found
Impact of anxiety and depression disorders on adherence to anticoagulant therapy among patients with atrial fibrillation
Aim. To determine the possible impact of anxiety and depression disorders on the adherence of patients with atrial fibrillation (AF) to anticoagulant the rapy.MaterialΒ andΒ methods. The study included outpatients with AF of any type. After signing the informed consent, patients filled out questionnaires and scales that determined the level of anxiety and personal predisposition (MMAS-8, MMAS-4, SF-36, SHAI, STAI, HADS, NEO-FFI).Results. A total of 117 outpatients treated for AF were included. The mean age of patients was 74Β±5 years (men, 38%). Based on MMAS-4 and MMAS-8 results, adherent and non-adherent cohorts of patients were formed. Low adherence group had significantly higher situational anxiety according to STAI (45,9Β±9,9 vs 41,1Β±10,7, p=0,045) and depression according to HADS (7,9Β±3,6 vs 5,9Β±3,5, p=0,018). SF 36 showed that non-adherent patients had a lower general health (41,6Β±12,9 vs 52,2Β±20,0, p=0,01). Five-factor model revealed an association between low compliance and low extraversion (21,3Β±6,6 vs 26,4Β±7,2, p=0,002). Pharmacokinetic data on blood concentrations of anticoagulants or its metabolites at the second visit were available in 76 (67%) patients. Assessment of pharmacokinetic and compliance data revealed a moderate direct correlation (Matthews correlation coefficient (MCC), 0,345) and a weak direct correlation with the MMAS-8 (MCC, 0,177). The difference in MMAS-4 and MMAS-8 scores between high and low pharmacokinetic adherence groups was significant on both scales (p=0,011 and 0,015, respectively).Conclusion.Β The rationale for widespread introduction of standardized questionnaires and scales (MMAS 4, MMAS 8, STAI, HADS, SF 36, Big 5) was shown in order to early identify patients with low adherence to treatment. The results highlight the need for further study of the contribution of psychiatric disorders to low compliance to anticoagulant therapy
ΠΡΠΈΡ ΠΎΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π° Π² ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅
The relevance of studying psychosomatic disorders in somatic clinical practice (including pulmonary practice) stems from the significant prevalence of these disorders, as well as the difficulties in making a differential diagnosis and choosing the most effective tactics for patient management.The aim of this review was to analyze the available publications on the problem of psychosomatic functional disorders in pulmonary practice, such as hyperventilation syndrome (HVS), including HVS associated with Severe Acute Respiratory Syndrome-related CoronaVirus 2 (SARS-CoV-2) infection, vocal cord dysfunction, and psychogenic cough. The article discusses clinical features of different variants of functional disorders and accompanying psychopathological symptoms (panic attacks, generalized anxiety, etc.), as well as psychogenic factors of their manifestation and changes in the clinical features over time. The corresponding section briefly summarizes current ideas about approaches to effective treatment of this group of disorders and prevention of their chronification.Conclusion. The clinical heterogeneity of psychosomatic functional disorders in pulmonological practice has been demonstrated, as have important aspects of the diagnosis and treatment of these disorders.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΏΡΠΈΡ
ΠΎΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² (ΠΠ‘Π ) Π² ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ΅ (Π² Ρ. Ρ. ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅) ΠΏΡΠΎΠ΄ΠΈΠΊΡΠΎΠ²Π°Π½Π° Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡΡ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΠΌΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΡΡΠ΄Π½ΠΎΡΡΡΠΌΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΠΈ Π²ΡΠ±ΠΎΡΠ° Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠ°ΠΊΡΠΈΠΊΠΈ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ².Π¦Π΅Π»ΡΡ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ ΠΎΠ±Π·ΠΎΡΠ° ΡΠ²ΠΈΠ»ΡΡ Π°Π½Π°Π»ΠΈΠ· Π΄ΠΎΡΡΡΠΏΠ½ΡΡ
ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΉ ΠΏΠΎ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΠ‘Π Π² ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ β Π³ΠΈΠΏΠ΅ΡΠ²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΎΠ½Π½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ (ΠΠΠ‘), Π²ΠΊΠ»ΡΡΠ°Ρ ΠΠΠ‘, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Ρ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ΅Π½Π½ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ SARS-CoV-2 (Severe Acute Respiratory Syndrome-related CoronaVirus 2), Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΡ Π³ΠΎΠ»ΠΎΡΠΎΠ²ΡΡ
ΡΠ²ΡΠ·ΠΎΠΊ ΠΈ ΠΏΡΠΈΡ
ΠΎΠ³Π΅Π½Π½ΡΠΉ ΠΊΠ°ΡΠ΅Π»Ρ. ΠΠ±ΡΡΠΆΠ΄Π°ΡΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² ΠΈ ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠ΅ΠΉ ΠΏΡΠΈΡ
ΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΡΠΈΠΊΠΈ (ΠΏΠ°Π½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠ°ΠΊΠΈ, Π³Π΅Π½Π΅ΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½Π°Ρ ΡΡΠ΅Π²ΠΎΠ³Π° ΠΈ ΠΏΡ.), Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΈΡ
ΠΎΠ³Π΅Π½Π½ΡΠ΅ ΡΠ°ΠΊΡΠΎΡΡ ΠΈΡ
ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ. ΠΡΠ°ΡΠΊΠΎ ΡΠ΅Π·ΡΠΌΠΈΡΠΎΠ²Π°Π½Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π°Ρ
ΠΊ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² ΡΡΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΈΡ
Ρ
ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ Π³Π΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΠΠ‘Π Π² ΠΏΡΠ»ΡΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅, ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π²Π°ΠΆΠ½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π΄Π°Π½Π½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ
Π’ΠΈΠΏΠΎΠ»ΠΎΠ³ΠΈΡ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² Π»ΠΈΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΏΡΠΈ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π»Π΅Π³ΠΊΠΈΡ
Summary. Patterns of disease-related psychological response, some of which are anxiety and depression, determine the adherence to treatment, the course and prognosis of the disease. Though an important role of disease-related psychological response is accepted in international guidelines on the management of chronic obstructive pulmonary disease (COPD), this problem and the patients' personality traits require further investigations.The aim of this study was to investigate relationships between COPD-related psychological response and personality disorders (PD) in COPD patients. The study sample included 56 patients (mean age 64.6 Β± 8.5 years) admitted to a clinical hospital of I.M. Sechenov's Medical University. All patients were observed by a psychiatrist, psychologist and therapist. Psychometric scales (Beck Depression Inventory scale (BDI), projective psychological questionnaires "Color Relation Test" and "Draw-A-Person test") and the Russian-version SF-36 were used. Basic types of COPD-related psychological response and PD have been determined. In hyponosognostic patients (51.9 %), a dissociative PD was predominantly found (34.5 % of patients with this response type); in neurotic hypochondria (health-related anxiety) patients (32.1 %), histrionic PD prevailed (38.9 %); and in depressive patients (8.9 %), hypertimic PD was diagnosed more often (60 %). Personality traits significantly contributed to the COPD-related psychological response. These results could be used to improving the COPD patient's therapy and rehabilitation.Π Π΅Π·ΡΠΌΠ΅. Π’ΠΈΠΏΡ ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π° ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ (Π‘Π), ΡΠ°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ ΡΡΠ΅Π²ΠΎΠ³Π° ΠΈ Π΄Π΅ΠΏΡΠ΅ΡΡΠΈΡ, Π²ΠΎ ΠΌΠ½ΠΎΠ³ΠΎΠΌ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡ ΠΏΡΠΈΠ²Π΅ΡΠΆΠ΅Π½Π½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ· Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π±ΠΎΠ»ΡΡΡΡ ΡΠΎΠ»Ρ ΡΠΈΠΏΠΎΠ² ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π·Π°ΠΊΡΠ΅ΠΏΠ»Π΅Π½Π½ΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ Π΄ΠΎΠΊΡΠΌΠ΅Π½ΡΠ°ΠΌΠΈ ΠΏΠΎ ΠΌΠ΅Π½Π΅Π΄ΠΆΠΌΠ΅Π½ΡΡ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π»Π΅Π³ΠΊΠΈΡ
(Π₯ΠΠΠ), ΡΡΠ° ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ°, ΠΊΠ°ΠΊ ΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠ½ΡΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ, ΡΠΏΠΎΡΠΎΠ±Π½ΡΠ΅, Π² ΡΠ²ΠΎΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ, Π²Π½ΠΎΡΠΈΡΡ Π²ΠΊΠ»Π°Π΄ Π² ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΎ Π±ΠΎΠ»Π΅Π·Π½ΠΈ, ΠΎΡΡΠ°ΡΡΡΡ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ ΠΈΠ·ΡΡΠ΅Π½Π½ΡΠΌΠΈ. Π¦Π΅Π»ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΡΠΈΠΏΠΎΠ² ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ² Π»ΠΈΡΠ½ΠΎΡΡΠΈ (Π Π) Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯ΠΠΠ.ΠΡΠ±ΠΎΡΠΊΠ° ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 56 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ β 64,6 Β± 8,5 Π³ΠΎΠ΄Π°) Π£ΠΠ β 1 ΠΠ΅ΡΠ²ΠΎΠ³ΠΎ ΠΠΠΠ£ ΠΈΠΌ. Π.Π.Π‘Π΅ΡΠ΅Π½ΠΎΠ²Π°. ΠΡΠ΅ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π±ΡΠ»ΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΏΡΠΈΡ
ΠΈΠ°ΡΡΠΎΠΌ, ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΎΠΌ ΠΈ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΎΠΌ. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈΡΡ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ ΠΏΡΠΈΡ
ΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΊΠ°Π»Ρ: ΡΠΊΠ°Π»Π° Beck Depression Inventory (BDI), ΠΏΡΠΎΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠΈ "Π¦Π²Π΅ΡΠΎΠ²ΠΎΠΉ ΡΠ΅ΡΡ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΉ" ΠΈ "ΠΡΠΎΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΠΈΡΡΠ½ΠΎΠΊ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°". ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΎΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΡΡΡΡΠΊΠΎΡΠ·ΡΡΠ½ΠΎΠΉ Π²Π΅ΡΡΠΈΠΈ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ° SF-36. ΠΡΠ»ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠΈΠΏΡ ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π° Π‘Π ΠΈ Π Π, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΈΡ
ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π₯ΠΠΠ. ΠΡΠΈ Π°Π±Π΅ΡΡΠ°Π½ΡΠ½ΠΎΠΉ ΠΈΠΏΠΎΡ
ΠΎΠ½Π΄ΡΠΈΠΈ (Π³ΠΈΠΏΠΎΠ½ΠΎΠ·ΠΎΠ³Π½ΠΎΠ·ΠΈΡ), Π²ΡΡΠ²Π»Π΅Π½Π½ΠΎΠΉ Ρ 51,9 % Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ, Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ Π±ΡΠ»ΠΎ Π΄ΠΈΡΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠ΅ Π Π (34,5 %); ΠΏΡΠΈ Π½Π΅Π²ΡΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠΏΠΎΡ
ΠΎΠ½Π΄ΡΠΈΠΈ (ΡΡΠ΅Π²ΠΎΠ³Π° Π·Π° Π·Π΄ΠΎΡΠΎΠ²ΡΠ΅) Ρ 32,1 % Π±ΠΎΠ»ΡΠ½ΡΡ
Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»ΠΎΡΡ ΠΈΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π Π (38,9 %); ΠΏΡΠΈ Π΄Π΅ΠΏΡΠ΅ΡΡΠΈΠΈ (8,9 %) β Π³ΠΈΠΏΠ΅ΡΡΠΈΠΌΠ½ΠΎΠ΅ Π Π (60 %).Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Π»ΠΈΡΠ½ΠΎΡΡΠ½ΡΠ΅ ΡΠ΅ΡΡΡ Π²Π½ΠΎΡΡΡ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ Π²ΠΊΠ»Π°Π΄ Π² ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΠΏΠΎΠ² ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π° Π‘Π. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΌΠΎΠ³ΡΡ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π΄Π»Ρ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅ΡΠ΅Π±Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π₯ΠΠΠ
TOWARDS A CLASSIFICATION ISSUE OF PSYCHIATRIC DISORDERS IN CARDIOLOGY (DISPUTABLE ASPECTS OF THE ARTICLE BY DROBIZHEV M. YU., KIKTA S.V., MACHILSKY O.V., βCARDIOPSYCHIATRY. TRANSLATION ISSUESβ)
The article is on the discussion of the article by Drobizhev M. Yu., Kikta S. V., Machilsky O. V. βCardiopsychiatry. Translation issuesβ, published in Cardiovascular Therapy and Prevention 2016; 15(4): 88-97. The authors propose classification of cardiopsychiatric disorders which is based only on literary data and is itself just a reductionist attempt to relate neurophysiological mechanisms with complex psychopathological and psychosomatic compounds being reified at the level of cardiovascular system. Also, it cannot be agreed, the publication part on psychopharmacotherapy of psychiatric disorders cardiological practice, where the authors position is just an application of one single medication
DIFFERENT APPROACHES TO THERAPY OF DEPRESSIVE DISORDERS IN CLINICAL PRACTICE
Depressive disorders, being the most common psychiatric pathology in general somatic practice, often act as a cause of aggravation of somatic/neurological pathology, increasing the risk of disability and death of patients. There is no uniform clinical pattern to the depressive disorders. Neurotic depression, nosogeny/somatogeny, and somatoreactive cyclothymia are the most common in the general medicine. Due to variety of clinical forms of affective diseases, they should be detected in a timely manner and referred for appropriate differentiated antidepressant treatment. As a prescribed drug, you should opt for an antidepressant that has an optimally balanced effect, fewer side effects and a minimal interaction with other drugs
Somatic depression with cognitive impairment in a female patient with hypertension
The paper describes a clinical case of hypertension and somatic depression in a female patient. It considers the differential diagnosis ofΒ somatic symptomatology within affective disorders, depicts the manifestations of a somatic disease, and analyzes the aspects of personal predispositionΒ to a mental disorder. The authors note theΒ advantages of an interdisciplinary approach to therapy withΒ antihypertensive drugs andΒ antidepressants and psychotherapy. OfΒ particular interest is the problem in the diagnosis and therapy ofΒ moderate cognitive impairment in aΒ patient with cardiac and psychiatric comorbidities
DEPRESSION IN NEUROLOGICAL PRACTICE
The article presents a short literature review on depressive disorders in neurological practice. It summarizes information on the prevalence rates for depressive disorders in the main forms of neurological pathology, their negative impact on the quality of life and the course of a neurological disease, the clinical features of the affective pathology in certain diseases, and modern approaches to the therapy of depression comorbid with neurological disorders. The article is illustrated with a clinical case that confirms the importance of timely diagnostics and treatment of depressive disorders
Chronic back pain and mental disorders
Chronic back pain is a significant biomedical problem due to its high prevalence and negative impact on quality of life and socioeconomic indicators. Mental disorders play a substantial role in the genesis of chronic pain. This review discusses the issues of back pain comorbid with depressive, anxiety disorders, post-traumatic stress disorder, and somatoform disorder. It also considers the features of the clinical manifestations of pain associated with mental disorders. There are data on the neurobiological relationship between pain and mental disorders and on the personality traits of patients with chronic back pain